| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diarrhea | D003967 | 32 associated lipids |
| Diphtheria | D004165 | 2 associated lipids |
| Drug Hypersensitivity | D004342 | 20 associated lipids |
| Duodenitis | D004382 | 4 associated lipids |
| Duodenogastric Reflux | D004383 | 2 associated lipids |
| Dyspepsia | D004415 | 5 associated lipids |
| Dyspnea | D004417 | 10 associated lipids |
| Ecchymosis | D004438 | 3 associated lipids |
| Empyema | D004653 | 3 associated lipids |
| Empyema, Tuberculous | D004654 | 1 associated lipids |
clarithromycin
clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
Cross Reference
Introduction
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with clarithromycin?
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (63)
- J. Antimicrob. Chemother. (56)
- J. Clin. Microbiol. (39)
- Others (258)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with clarithromycin
PubChem Associated disorders and diseases
What pathways are associated with clarithromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with clarithromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Antimicrob. Chemother. (25)
- Antimicrob. Agents Chemother. (20)
- J. Clin. Microbiol. (9)
- Others (66)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with clarithromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with clarithromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with clarithromycin?
Related references are published most in these journals:
- J. Antimicrob. Chemother. (20)
- Antimicrob. Agents Chemother. (17)
- J. Clin. Microbiol. (13)
- Others (57)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with clarithromycin?
Mouse Model
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with clarithromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Espinal DA et al. | [Human metapneumovirus in children: first cases in Colombia]. | 2012 | Biomedica | pmid:23242289 |
| Figueroa M et al. | [Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis]. | 2012 Jan-Mar | Biomedica | pmid:23235785 |
| Reed PI and Johnston BJ | Treatment of Helicobacter pylori infection. | 1997 | Biomed. Pharmacother. | pmid:9084725 |
| Li W et al. | Liquid chromatographic-electrospray tandem mass spectrometric determination of clarithromycin in human plasma. | 2006 | Biomed. Chromatogr. | pmid:16838265 |
| Niopas I and Daftsios AC | Determination of clarithromycin in human plasma by HPLC with electrochemical detection: validation and application in pharmacokinetic study. | 2001 | Biomed. Chromatogr. | pmid:11748684 |
| Kousoulos C et al. | Validation of a fully automated high throughput liquid chromatographic/tandem mass spectrometric method for roxithromycin quantification in human plasma. Application to a bioequivalence study. | 2008 | Biomed. Chromatogr. | pmid:18059078 |
| Angol DC et al. | from Peptic Ulcer Patients in Uganda Is Highly Resistant to Clarithromycin and Fluoroquinolones: Results of the GenoType HelicoDR Test Directly Applied on Stool. | 2017 | Biomed Res Int | pmid:28555193 |
| Nie W et al. | Species Identification and Clarithromycin Susceptibility Testing of 278 Clinical Nontuberculosis Mycobacteria Isolates. | 2015 | Biomed Res Int | pmid:26146620 |
| Tai WC et al. | Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A" Success Rate for First-Line Helicobacter pylori Eradication. | 2015 | Biomed Res Int | pmid:26090428 |
| Patel SK et al. | Helicobacter pylori is not eradicated after triple therapy: a nested PCR based study. | 2014 | Biomed Res Int | pmid:25054141 |
| Peric A et al. | Influence of allergy on the immunomodulatory and clinical effects of long-term low-dose macrolide treatment of nasal polyposis. | 2010 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | pmid:21293544 |
| Dogan Z et al. | The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study. | 2015 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | pmid:24993741 |
| Liang CM et al. | Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice. | Biomed J | pmid:25163495 | |
| Vijayananthan A et al. | Mastoiditis secondary to mycobacterium abscessus imaged with gallium-67 scintigraphy. | 2008 | Biomed Imaging Interv J | pmid:21614326 |
| Roccaro AM et al. | Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias. | 2008 | Biologics | pmid:19707373 |
| Prakash S and Urbanska AM | Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells. | 2008 | Biologics | pmid:19707368 |
| Yoneda K et al. | In vitro metabolism and inhibitory effects of pranlukast in human liver microsomes. | 2009 | Biol. Pharm. Bull. | pmid:19336906 |
| Matsui E et al. | The influence of glycyrrhiza and antibiotics on the purgative action of sennoside a from Daiokanzoto in mice. | 2011 | Biol. Pharm. Bull. | pmid:21881230 |
| Ishii K et al. | A new pharmacokinetic model including in vivo dissolution and gastrointestinal transit parameters. | 1995 | Biol. Pharm. Bull. | pmid:7550125 |
| Miyamoto D et al. | Clarithromycin inhibits progeny virus production from human influenza virus-infected host cells. | 2008 | Biol. Pharm. Bull. | pmid:18239276 |
| Togami K et al. | Subcellular distribution of azithromycin and clarithromycin in rat alveolar macrophages (NR8383) in vitro. | 2013 | Biol. Pharm. Bull. | pmid:23995662 |
| Hanawa T et al. | In vitro antibacterial activity of Phx-3 against Helicobacter pylori. | 2010 | Biol. Pharm. Bull. | pmid:20118538 |
| Komori T et al. | Effects of repeated clarithromycin administration on the pharmacokinetic properties of pindolol in rats. | 1998 | Biol. Pharm. Bull. | pmid:9881659 |
| Masa K et al. | Effect of clarithromycin and other macrolides on the sulfoxidation and 5-hydroxylation of lansoprazole in dogs. | 1999 | Biol. Pharm. Bull. | pmid:10375172 |
| Zaidi SF et al. | Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori. | 2009 | Biol. Pharm. Bull. | pmid:19336896 |
| Kido H et al. | Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential. | 2004 | Biol. Chem. | pmid:15576322 |
| Mark T et al. | Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma. | 2008 | Biol. Blood Marrow Transplant. | pmid:18541199 |
| Panozzo C et al. | Chemicals or mutations that target mitochondrial translation can rescue the respiratory deficiency of yeast bcs1 mutants. | 2017 | Biochim. Biophys. Acta | pmid:28888990 |
| Sinan S et al. | Amphenicol and macrolide derived antibiotics inhibit paraoxonase enzyme activity in human serum and human hepatoma cells (HepG2) in vitro. | 2006 | Biochemistry Mosc. | pmid:16457617 |
| Burgie ES and Holden HM | Molecular architecture of DesI: a key enzyme in the biosynthesis of desosamine. | 2007 | Biochemistry | pmid:17630700 |
| Komori T et al. | Up-regulation by clarithromycin of alpha(1)-acid glycoprotein expression in liver and primary cultured hepatocytes. | 2001 | Biochem. Pharmacol. | pmid:11709199 |
| Yamamoto S et al. | Mitochondrial proteins NIP-SNAP-1 and -2 are a target for the immunomodulatory activity of clarithromycin, which involves NF-κB-mediated cytokine production. | 2017 | Biochem. Biophys. Res. Commun. | pmid:27998764 |
| Wang EJ et al. | Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11716514 |
| Yamanaka Y et al. | Gene expression profiles of human small airway epithelial cells treated with low doses of 14- and 16-membered macrolides. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11549274 |
| Sugita S et al. | EGFR-independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non-small cell lung cancer cells. | 2015 | Biochem. Biophys. Res. Commun. | pmid:25858318 |
| Komatsu S et al. | Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells. | 2013 | Biochem. Biophys. Res. Commun. | pmid:23792097 |
| Highleyman L | FDA issues Hismanal warning. Food and Drug Administration. | 1998 | BETA | pmid:11365263 |
| Bartnof HS | OIs and cancers. | 1999 | BETA | pmid:11367262 |
| Wolle K and Malfertheiner P | Treatment of Helicobacter pylori. | 2007 | Best Pract Res Clin Gastroenterol | pmid:17382279 |
| Pilotto A | Aging and upper gastrointestinal disorders. | 2004 | Best Pract Res Clin Gastroenterol | pmid:15588798 |
| Chen SA et al. | HLA-A*02:07 Allele Associates with Clarithromycin-Induced Cutaneous Adverse Drug Reactions in Chinese Patients. | 2018 | Basic Clin. Pharmacol. Toxicol. | pmid:29575644 |
| Gao X et al. | Suppression of inducible nitric oxide synthase expression and nitric oxide production by macrolide antibiotics in sulfur mustard-exposed airway epithelial cells. | 2008 | Basic Clin. Pharmacol. Toxicol. | pmid:18684233 |
| Hajiioannou JK et al. | Clarithromycin induced reversible sensorineural hearing loss. | 2011 | B-ENT | pmid:21838098 |
| Ledwoń A et al. | Multidrug therapy of Mycobacterium avium subsp. avium infection in experimentally inoculated budgerigars (Melopsittacus undulatus). | 2015 | Avian Pathol. | pmid:26364975 |
| Simjee S et al. | Antimicrobial susceptibility and distribution of antimicrobial-resistance genes among Enterococcus and coagulase-negative Staphylococcus isolates recovered from poultry litter. | 2007 | Avian Dis. | pmid:18251398 |
| Phan TA and Relic J | Sporotrichoid Mycobacterium marinum infection of the face following a cat scratch. | 2010 | Australas. J. Dermatol. | pmid:20148843 |
| Orrin E et al. | Sporotrichoid Mycobacterium chelonae. | 2016 | Australas. J. Dermatol. | pmid:27469486 |
| Ricciardo B et al. | Mycobacterium abscessus infection complicating a professional tattoo. | 2010 | Australas. J. Dermatol. | pmid:21198529 |
| Ozluer SM and De'Ambrosis BJ | Mycobacterium abscessus wound infection. | 2001 | Australas. J. Dermatol. | pmid:11233716 |
| Bennie CJ et al. | In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine. | Aust. Vet. J. | pmid:25622709 | |
| Lucas J et al. | Mycobacterium genavense infection in two aged ferrets with conjunctival lesions. | 2000 | Aust. Vet. J. | pmid:11098383 |
| Malik R et al. | Treatment of canine leproid granuloma syndrome: preliminary findings in seven dogs. | 2001 | Aust. Vet. J. | pmid:11221566 |
| Lunn JA et al. | Pneumonia due to Mycobacterium abscessus in two domestic ferrets (Mustelo putorius furo). | 2005 | Aust. Vet. J. | pmid:16164141 |
| Gioulekas J and Hall A | Uveitis associated with rifabutin therapy. | 1995 | Aust N Z J Ophthalmol | pmid:11980079 |
| Kaushik SP and Vu C | Helicobacter pylori eradication with lansoprazole, amoxycillin and clarithromycin: testing an ideal regimen in a multicultural south east Asian population and examining factors potentially influencing eradication. | 2000 | Aust N Z J Med | pmid:10833116 |
| Fraser AG et al. | Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit. | 1999 | Aust N Z J Med | pmid:10868529 |
| Bradbeer L et al. | Childhood headache and H. pylori--a possible association. | 2013 | Aust Fam Physician | pmid:23529524 |
| Chen K et al. | Low dose macrolide administration for long term is effective for otitis media with effusion in children. | 2013 | Auris Nasus Larynx | pmid:22673738 |
| Majima Y et al. | Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp. | 2012 | Auris Nasus Larynx | pmid:21636230 |
| Tojima I et al. | Anti-inflammatory effects of a novel non-antibiotic macrolide, EM900, on mucus secretion of airway epithelium. | 2015 | Auris Nasus Larynx | pmid:25769240 |
| Enomoto F et al. | Effect of new macrolides on the expression of adhesion molecules on neutrophils in chronic sinusitis. | 2002 | Auris Nasus Larynx | pmid:12167449 |
| Sugimoto H et al. | A case of chronic otitis media caused by Mycobacterium abscessus. | 2010 | Auris Nasus Larynx | pmid:20206453 |
| Jang YJ et al. | Maxillary sinus hypoplasia with a patent ostiomeatal complex: A therapeutic dilemma. | 2012 | Auris Nasus Larynx | pmid:21571467 |
| Nakamura Y et al. | Optimal duration of macrolide treatment for chronic sinusitis after endoscopic sinus surgery. | 2013 | Auris Nasus Larynx | pmid:23107100 |
| Shimizu T and Suzaki H | Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan. | 2016 | Auris Nasus Larynx | pmid:26441370 |
| Paju S et al. | Clarithromycin reduces recurrent cardiovascular events in subjects without periodontitis. | 2006 | Atherosclerosis | pmid:16388809 |
| Gené E et al. | [Seven or ten days? Cost-effectiveness study on the duration of H. pylori treatment in primary care]. | 2006 | Aten Primaria | pmid:17198608 |
| Vernet Vernet M et al. | [Analysis of indications and diagnosis of the gastroscopies requested by primary care physicians]. | 2000 | Aten Primaria | pmid:10795440 |
| Solé López J et al. | [Consumption of antibiotics and their possible relationship with bacterial resistance in the "Costa de Ponent" health region: analysis of evolution through the initial and end periods of the last decade]. | Aten Primaria | pmid:15274900 | |
| Baena DÃez JM et al. | [Treatment with omeprazole, clarithromycin and amoxicillin for one week. Their efficacy and tolerance in eradicating Helicobacter pylori in primary care]. | 1998 | Aten Primaria | pmid:9887574 |
| Sanfélix Genovés J et al. | [Helicobacter pylori: 6-day triple therapy in duodenal ulcer]. | 1998 | Aten Primaria | pmid:9670578 |
| Gené E et al. | [Management of dyspepsia, gastroduodenal ulcer and Helicobacter pylori infection in primary care]. | 2002 | Aten Primaria | pmid:12031222 |
| Pandey R et al. | Helicobacter pylori and gastric cancer. | 2010 | Asian Pac. J. Cancer Prev. | pmid:21039020 |
| Tongtawee T et al. | Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial. | 2015 | Asian Pac. J. Cancer Prev. | pmid:26163609 |
| Prapitpaiboon H et al. | High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand. | 2015 | Asian Pac. J. Cancer Prev. | pmid:26028098 |
| Phiphatpatthamaamphan K et al. | Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study. | 2016 | Asian Pac. J. Cancer Prev. | pmid:27221874 |
| Srinarong C et al. | Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand. | 2014 | Asian Pac. J. Cancer Prev. | pmid:25520127 |
| Vannarath S et al. | Antibiotic Resistant Pattern of Helicobacter Pylori Infection Based on Molecular Tests in Laos. | 2016 | Asian Pac. J. Cancer Prev. | pmid:26838225 |
| Tongtawee T et al. | High Prevalence of Helicobacter pylori Resistance to Clarithromycin: a Hospital-Based Cross-Sectional Study in Nakhon Ratchasima Province, Northeast of Thailand. | 2015 | Asian Pac. J. Cancer Prev. | pmid:26745073 |
| Abdul Aziz AF et al. | Helicobacter pylori related dyspepsia: prevalence and treatment outcomes at University Kebangsaan Malaysia-Primary Care Centre. | 2009 | Asia Pac Fam Med | pmid:19435494 |
| Klotz U | Interaction potential of lercanidipine, a new vasoselective dihydropyridine calcium antagonist. | 2002 | Arzneimittelforschung | pmid:11963641 |
| Koytchev R et al. | Studies on the bioequivalence of different strengths of tablets containing clarithromycin. | 2004 | Arzneimittelforschung | pmid:15497665 |
| Koytchev R et al. | Clarithromycin suspension: bioequivalence studies on two different strengths. | 2004 | Arzneimittelforschung | pmid:15497666 |
| Frotz H et al. | [Ranitidine and clarithromycin for eradication of Helicobacter pylori in patients with duodenal ulcer]. | 1995 | Arzneimittelforschung | pmid:7710445 |
| Zakeri-Milani P et al. | Pharmacokinetics and comparative bioavailability study of two clarithromycin suspensions following administration of a single oral dose to healthy volunteers. | 2009 | Arzneimittelforschung | pmid:19813467 |
| Lombardi A et al. | Antimicrobial activity of thiamphenicol-glycinate-acetylcysteinate and other drugs against Chlamydia pneumoniae. | 2001 | Arzneimittelforschung | pmid:11304944 |
| Ullah S et al. | Hydrophilically modified self-assembling α-tocopherol derivative as niosomal nanocarrier for improving clarithromycin oral bioavailability. | 2018 | Artif Cells Nanomed Biotechnol | pmid:28541761 |
| Terkeltaub RA et al. | Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors. | 2011 | Arthritis Rheum. | pmid:21480191 |
| Anim-Appiah D et al. | Mycobacterium avium complex tenosynovitis of the wrist and hand. | 2004 | Arthritis Rheum. | pmid:14872467 |
| Mangat P et al. | Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis? | 2010 | Arthritis Res. Ther. | pmid:20553633 |
| Eisig JN et al. | The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy. | 2003 Jan-Mar | Arq Gastroenterol | pmid:14534667 |
| Araújo-Filho I et al. | Prevalence of Helicobacter pylori infection in advanced gastric carcinoma. | Arq Gastroenterol | pmid:17406757 | |
| Martins GM et al. | MOLECULAR DETECTION OF CLARITHROMYCIN AND FLUOROQUINOLONES RESISTANCE IN HELICOBACTER PYLORI INFECTION, DIRECTLY APPLIED TO GASTRIC BIOPSIES, IN AN URBAN BRAZILIAN POPULATION. | Arq Gastroenterol | pmid:27305419 | |
| Lins AK et al. | Clarithromycin-resistant Helicobacter pylori in Recife, Brazil, directly identified from gastric biopsies by polymerase chain reaction. | 2010 Oct-Dec | Arq Gastroenterol | pmid:21225149 |
| Kawakami E et al. | Triple therapy with clarithromycin, amoxicillin and omeprazole for Helicobacter pylori eradication in children and adolescents. | 2001 Jul-Sep | Arq Gastroenterol | pmid:11917721 |
| Batista CA et al. | Neither genotype nor the gastric colonization site of Helicobacter pylori are predictive factors for the development of erosive esophagitis in patients with peptic ulcer disease, 1 year after eradication. | 2009 Jul-Sep | Arq Gastroenterol | pmid:19918687 |
| Coelho LG et al. | [Efficacy of the dosing regimen of pantoprazole 40 mg, amoxicillin 1000 mg and clarithromycin 500 mg, twice daily for 7 days, in the eradication of Helicobacter pylori in patients with peptic ulcer]. | 2004 Jan-Mar | Arq Gastroenterol | pmid:15499429 |
| Asgari B et al. | HONEY-DERIVED LACTOBACILLUS RHAMNOSUS ALLEVIATES HELICOBACTER PYLORI-INDUCED GASTRO-INTESTINAL INFECTION AND GASTRIC INFLAMMATION IN C57BL/6 MICE: AN IMMUNO-HISTOLOGIC STUDY. | Arq Gastroenterol | pmid:30540092 | |
| Eisig JN et al. | Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option. | 2011 Oct-Dec | Arq Gastroenterol | pmid:22147131 |
| Kogan EA et al. | [The role of apoptosis and proliferation of epitheliocytes in morphogenesis of Helicobacter pylori-associated gastritis]. | 2003 Nov-Dec | Arkh. Patol. | pmid:14964963 |